Gland Pharma Limited
GLAND
Pozycja w akcjach
#3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Cena akcji
$32.32
Kapitalizacja rynkowa
$5.33B
Zmiana (1 dzień)
-3.01%
Zmiana (1 rok)
47.99%
Kraj
IN
Handel Gland Pharma Limited (GLAND)
Kategoria
Healthcare
Wskaźnik P/B dla Gland Pharma Limited (GLAND)
Wskaźnik P/B na dzień October 2026 TTM: 4.84
Według najnowszych raportów finansowych i ceny akcji Gland Pharma Limited, obecny wskaźnik P/B (TTM) wynosi 4.84. Na koniec 2024 wynosił 3.43.
Historia wskaźnika P/B dla Gland Pharma Limited od 2017 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 4.84 | 72.92% |
| 2025 | 2.80 | -18.34% |
| 2024 | 3.43 | 30.55% |
| 2023 | 2.62 | -65.05% |
| 2022 | 7.51 | 13.10% |
| 2021 | 6.64 | -14.17% |
| 2020 | 7.73 | -25.51% |
| 2019 | 10.38 | -15.78% |
| 2018 | 12.33 | -8.64% |
| 2017 | 13.49 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 4.11% |
IN
|
